publication date: Jun. 14, 2013

Vol. 39, No. 24 – 

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling FASEB: Focus on Research Funding, Not PR MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee

Download the PDF

Documents related to this issue of The Cancer Letter can be found here.

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.